Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
Mutlu HizalMehmet An SendurHatime Arzu YasarKadriye Bir YucelCagatay ArslanGokhan UcarSerdar KarakayaHakan TabanAhmet KucukardaIsmail ErturkBurak BilginNuriye YıldırımUmut DemirciSaadettin KılıckapIrfan CicinNuri KaradurmusBulent YalcinYuksel UrunPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
In conclusion, the pre-treatment value of elevated neutrophil-lymphocyte ratio might be a predictor of poor overall survival in advanced renal cell carcinoma patients.